首页> 美国卫生研究院文献>Journal of Carcinogenesis >Antisense oligonucleotides directed against insulin-like growth factor-II messenger ribonucleic acids delay the progress of rat hepatocarcinogenesis
【2h】

Antisense oligonucleotides directed against insulin-like growth factor-II messenger ribonucleic acids delay the progress of rat hepatocarcinogenesis

机译:针对胰岛素样生长因子-II信使核糖核酸的反义寡核苷酸延迟了大鼠肝癌发生的进程

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background:Hepatocellular carcinoma (HCC) is a multistep complex process, caused by many of genetic alteration. Insulin-like growth factors and their receptor have been widely implicated to HCC. Insulin-like growth factor-II (IGF-II) is a mitogenic polypeptide, found in various fetal and neonatal tissues of humans and rats and expresses in HCC. Here we investigated anticancer potential of phosphorothioate antisense oligonucleotides (ASOs) against three coding exons (exon-1/exon-2/exon-3) of IGF-II messenger ribonucleic acid in rat hepatocarcinogenesis model.
机译:背景:肝细胞癌(HCC)是一个多步骤的复杂过程,是由许多遗传变异引起的。胰岛素样生长因子及其受体已广泛涉及肝癌。胰岛素样生长因子-II(IGF-II)是一种有丝分裂多肽,存在于人类和大鼠的各种胎儿和新生儿组织中,并在HCC中表达。在这里,我们研究了硫代磷酸酯反义寡核苷酸(ASO)对大鼠肝癌发生模型中IGF-II信使核糖核酸的三个编码外显子(exon-1 / exon-2 / exon-3)的抗癌潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号